Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Abbott Laboratories    ABT

ABBOTT LABORATORIES (ABT)
Mes dernières consult.
Most popular
  Report  
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsofficial PublicationsSector newsTweets
The feature you requested does not exist. However, we suggest the following feature:

Abbott Laboratories : An Application for the Trademark "TARGETED, SPECIALIZED NUTRITION" Has Been Filed by Abbott Laboratories

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/26/2018 | 06:23pm CEST

By a News Reporter-Staff News Editor at Pharma Business Week -- According to news reporting originating from Washington, D.C., by NewsRx journalists, a trademark application has been made for "TARGETED, SPECIALIZED NUTRITION" by Cheryl A. Witycombe, representing Abbott Laboratories. This application was made available to the public on April 13, 2018 (see also Abbott Laboratories).

The serial number for this application is 85171321.

The international trademark goods and services class code for this trademark application is 005.

As submitted by the applicant, this trademark application relates to the following goods and services: Liquid and powder nutritive supplements for human use.

The owner/registrar information for this application is: Cheryl A. Witycombe, Abbott Laboratories, 100 Abbott Park Rd, Abbott Park, IL 60064-6008.

Keywords for this news article include: Pharmaceutical Companies, Business, Trademarks, Diet and Nutrition, Abbott Laboratories, Health and Medicine, Healthcare Companies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2018, NewsRx LLC

(c) 2018 NewsRx LLC, source Health Newsletters

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on ABBOTT LABORATORIES
06:23pABBOTT LABORATORIES : An Application for the Trademark "TARGETED, SPECIALIZED NU..
AQ
10:35aABBOTT LABORATORIES : Extends title sponsorship of world marathon majors through..
AQ
04/24ABBOTT LABORATORIES PAKISTAN : Financial results of Abbott Laboratories (Pakista..
AQ
04/23ABBOTT LABORATORIES : Sanquin Selects Abbott's "Alinity™ s" Solution for B..
PR
04/23ABBOTT LABORATORIES : Reports First-Quarter 2018 Results
AQ
04/23ABBOTT LABORATORIES : Holdings Reduced by Metropolitan Life Insurance Co. NY
AQ
04/20ABBOTT : Extends Title Sponsorship of Abbott : World Marathon Majors through 202..
PR
04/20ABBOTT LABORATORIES : Sens. Durbin, Duckworth Issue Statement on Nominations of ..
AQ
04/20ABBOTT LABORATORIES : New ensure max protein helps americans go for their health..
AQ
04/19ABBOTT LABORATORIES : An Application for the Trademark "VITAL" Has Been Filed by..
AQ
More news
News from SeekingAlpha
04/21THE PASSIVE DGI CORE PORTFOLIO : Income, Safety, And Growth 
04/20Danaher's Growing Leverage To Life Sciences Improves The Long-Term Outlook 
04/19Abbott Laboratories 2018 Q1 - Results - Earnings Call Slides 
04/18Abbott Laboratories' (ABT) CEO Miles White on Q1 2018 Results - Earnings Call.. 
04/18Abbott Q1 top line up 
Financials ($)
Sales 2018 31 081 M
EBIT 2018 6 458 M
Net income 2018 2 536 M
Debt 2018 15 152 M
Yield 2018 1,90%
P/E ratio 2018 45,00
P/E ratio 2019 31,93
EV / Sales 2018 3,76x
EV / Sales 2019 3,47x
Capitalization 102 B
Chart ABBOTT LABORATORIES
Duration : Period :
Abbott Laboratories Technical Analysis Chart | ABT | US0028241000 | 4-Traders
Technical analysis trends ABBOTT LABORATORIES
Short TermMid-TermLong Term
TrendsNeutralNeutralBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 68,5 $
Spread / Average Target 17%
EPS Revisions
Managers
NameTitle
Miles D. White Chairman & Chief Executive Officer
Brian B. Yoor Chief Financial Officer & Executive VP-Finance
Roxanne Schuh Austin Independent Director
Samuel C. Scott Independent Director
Glenn Fletcher Tilton Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
ABBOTT LABORATORIES2.17%101 829
JOHNSON & JOHNSON-9.68%338 522
PFIZER2.32%220 455
NOVARTIS-8.69%202 567
ROCHE HOLDING LTD.-11.66%193 904
MERCK AND COMPANY5.97%161 967